I have no insight, but it's possible that the FDA might accept P=0.06 for the primary endpoint.
The habit of arbitralily treating P<0.05 as significant and P=0.5 or greater as not signficant has been challenged by some statisticians in recent years, who have argued that other considerations should be taken into account when making a judgement. Time will tell.